It is possible that in MDS, DDIT3 is specifically upregulated in early phases of progenitor cell differentiation and commitment which is consistent with our results, showing that DDIT3 upregulation was more evident in HSCs than in total CD34+ cells. The gene discussed is DDIT3; the disease is myelodysplastic syndrome.